These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9501065)

  • 1. Overexpression of the transmembrane tyrosine phosphatase LAR activates the caspase pathway and induces apoptosis.
    Weng LP; Yuan J; Yu Q
    Curr Biol; 1998 Feb; 8(5):247-56. PubMed ID: 9501065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane tyrosine phosphatase LAR induces apoptosis by dephosphorylating and destabilizing p130Cas.
    Weng LP; Wang X; Yu Q
    Genes Cells; 1999 Mar; 4(3):185-96. PubMed ID: 10320483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X; Weng LP; Yu Q
    Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigen-related) on tyrosine dephosphorylation of insulin receptor.
    Tsujikawa K; Kawakami N; Uchino Y; Ichijo T; Furukawa T; Saito H; Yamamoto H
    Mol Endocrinol; 2001 Feb; 15(2):271-80. PubMed ID: 11158333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the transmembrane protein tyrosine phosphatase lar by 3S-peptide-I enhances insulin receptor phosphorylation in intact cells.
    Kole HK; Kole S; Mallory BP; Li PM; Goldstein BJ; Bernier M
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):111-26. PubMed ID: 10212829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR.
    Zhang WR; Li PM; Oswald MA; Goldstein BJ
    Mol Endocrinol; 1996 May; 10(5):575-84. PubMed ID: 8732688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells.
    Li PM; Zhang WR; Goldstein BJ
    Cell Signal; 1996 Nov; 8(7):467-73. PubMed ID: 9023010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular redistribution of protein tyrosine phosphatases LAR and PTPsigma by inducible proteolytic processing.
    Aicher B; Lerch MM; Müller T; Schilling J; Ullrich A
    J Cell Biol; 1997 Aug; 138(3):681-96. PubMed ID: 9245795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase.
    Cheung AT; Wang J; Ree D; Kolls JK; Bryer-Ash M
    Diabetes; 2000 May; 49(5):810-9. PubMed ID: 10905491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation.
    Mooney RA; Kulas DT; Bleyle LA; Novak JS
    Biochem Biophys Res Commun; 1997 Jun; 235(3):709-12. PubMed ID: 9207225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and expression of a unique receptor-like protein-tyrosine-phosphatase in the leucocyte-common-antigen-related phosphate family.
    Zhang WR; Hashimoto N; Ahmad F; Ding W; Goldstein BJ
    Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):39-47. PubMed ID: 8068021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
    Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
    Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAR tyrosine phosphatase receptor: a developmental isoform is present in neurites and growth cones and its expression is regional- and cell-specific.
    Zhang JS; Honkaniemi J; Yang T; Yeo TT; Longo FM
    Mol Cell Neurosci; 1998 Apr; 10(5-6):271-86. PubMed ID: 9604206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAR tyrosine phosphatase receptor: alternative splicing is preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing extensive CAG repeats.
    Zhang JS; Longo FM
    J Cell Biol; 1995 Feb; 128(3):415-31. PubMed ID: 7844155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphatase LAR in intact cells.
    Ahmad F; Goldstein BJ
    J Biol Chem; 1997 Jan; 272(1):448-57. PubMed ID: 8995282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the leucocyte common antigen-related (LAR) tyrosine phosphatase is regulated by cell density through functional E-cadherin complexes.
    Symons JR; LeVea CM; Mooney RA
    Biochem J; 2002 Jul; 365(Pt 2):513-9. PubMed ID: 12095414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte common-antigen-related tyrosine phosphatase receptor: altered expression of mRNA and protein in the New England Deaconess Hospital rat line exhibiting spontaneous pheochromocytoma.
    Yang T; Martignetti JA; Massa SM; Longo FM
    Carcinogenesis; 2000 Feb; 21(2):125-31. PubMed ID: 10657947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing.
    Ruhe JE; Streit S; Hart S; Ullrich A
    Cell Signal; 2006 Sep; 18(9):1515-27. PubMed ID: 16478662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue.
    Yang T; Zhang JS; Massa SM; Han X; Longo FM
    Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The leukocyte common antigen-related protein LAR: candidate PTP for inhibitory targeting.
    Mooney RA; LeVea CM
    Curr Top Med Chem; 2003; 3(7):809-19. PubMed ID: 12678846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.